The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7403
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly ; volume:19 ; number:2 ; day:20 ; month:8 ; year:2015 ; pages:210-221 ; date:4.2016
Pituitary ; 19, Heft 2 (20.8.2015), 210-221, 4.2016
- Creator
-
Colao, Annamaria
- Contributor
- DOI
-
10.1007/s11102-015-0677-y
- URN
-
urn:nbn:de:1111-2016032428992
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Colao, Annamaria
- Auriemma, Renata S.
- Pivonello, Rosario
- SpringerLink (Online service)
Other Objects (12)
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment